Cytotoxic t-lymphocytes (New York Medical College)

N/A

Report date: 2023/01/07 18:44:58

Base Information

Drug NameCytotoxic t-lymphocytes (New York Medical College)

Drug Alias NameEpstein-Barr Virus specific cytotoxic T cells( (New York Medical College)LMP1-MSD-TMV

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Cytotoxic T-lymphocytes therapy

Mechanisms of ActionCytotoxic T lymphocytes replacements

TargetsNot applicable

Therapy Area/IndicationsPrimary Immunodeficiency DiseasesEpstein-Barr Virus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesNew York Medical College

China Registration ClassN/A

Develop Information

Active CompaniesNew York Medical College

Inactive CompaniesN/A

Active IndicationsPrimary Immunodeficiency DiseasesEpstein-Barr Virus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A